Direkt zum Inhalt
Merck
  • Proteomic analysis reveals important role of 14-3-3σ in anoikis resistance of cholangiocarcinoma cells.

Proteomic analysis reveals important role of 14-3-3σ in anoikis resistance of cholangiocarcinoma cells.

Proteomics (2013-09-14)
Amnart Khongmanee, Kriengsak Lirdprapamongkol, Phanthakarn Tit-oon, Daranee Chokchaichamnankit, Jisnuson Svasti, Chantragan Srisomsap
ZUSAMMENFASSUNG

Cholangiocarcinoma (CCA), a high-prevalence cancer in Thailand, is highly metastatic and has high mortality rates. Anoikis resistance or the ability of cells to survive after detachment from extracellular matrix is a necessary property of metastatic cancer. Here, we report differential protein expression of an anoikis-resistant CCA cell line culture, under attachment conditions compared to nonattachment conditions, studied using 2DE coupled with protein identification by LC-MS/MS. Our data reveal the deregulation of proteins involved in stress response, cytoskeleton rearrangement, proapoptosis, cell proliferation, and glycolysis. Interestingly, 14-3-3σ (14-3-3 sigma) protein was intensely upregulated in detached CCA cells. Real-time RT-PCR analysis confirmed that only the sigma isotype was the most abundant transcript among 14-3-3 genes in CCA cells. Furthermore, silencing 14-3-3σ expression by small interfering RNA in CCA cells resulted in significantly increased percentage of cell death in detached culture. Our findings provide the first evidence showing that 14-3-3σ protein plays a crucial role in anoikis resistance of CCA cells. Therefore, 14-3-3σ might be a potential target in CCA therapy.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Proteasehemmer-Cocktail, for use with mammalian cell and tissue extracts, DMSO solution